Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of “regression to the mean” using routine clinical features with correlating biochemical relapse rates

Recommendations for managing clinically localized prostate cancer are structured around clinical risk criteria, with prostate biopsy (PB) Gleason score (GS) being the most important factor. Biopsy to radical prostatectomy (RP) specimen upgrading/downgrading is well described, and is often the ration...

Descripción completa

Detalles Bibliográficos
Autores principales: Altok, Muammer, Troncoso, Patricia, Achim, Mary F, Matin, Surena F, Gonzalez, Graciela N, Davis, John W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859655/
https://www.ncbi.nlm.nih.gov/pubmed/31115364
http://dx.doi.org/10.4103/aja.aja_29_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859655/
https://www.ncbi.nlm.nih.gov/pubmed/31115364
http://dx.doi.org/10.4103/aja.aja_29_19

Ejemplares similares